Molecular characterisation of patients with NPM1mutated acute myeloid leukaemia who enter deep remission without intensive chemotherapy: scientific correlates of the VICTOR trial.

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/2021 → 31/08/2024

Funding

  • Blood Cancer UK: £241,435.63